Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Point-of-care Measurement of the Antifibrinolytic Activity of Tranexamic Acid in Cardiac Surgery

NCT06128330 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT06128330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06128330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Point-of-care Measurement of the Antifibrinolytic Activity of Tranexamic Acid in Cardiac Surgery
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Phase 4
Overall status
Recruiting
Start date
December 15, 2023
Completion date
December 31, 2026
Enrollment
322 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antifibrinolytic agents